Host and environmental factors associated with Hib in England, 1998-2002

Archives of Disease in Childhood

Volumn 93, Issue 8, 2008, Pages 670-675

  McVernon, J ^a,b   Andrews, N ^a   Slack, M ^a   Moxon, R ^c   Ramsay, M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; ANTIINFECTIVE AGENT; HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE VACCINE; HAEMOPHILUS VACCINE;

ARTICLE; BACTERIAL INFECTION; CHILD; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HOST RESISTANCE; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PARENT; SOCIAL ISOLATION; UNITED KINGDOM; ANALYSIS OF VARIANCE; BACTERIAL MEMBRANE; CASE CONTROL STUDY; DAY CARE; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; QUESTIONNAIRE; RISK; RISK FACTOR; SOCIOECONOMICS;

ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BACTERIAL CAPSULES; CASE-CONTROL STUDIES; CHILD; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; ENGLAND; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; MALE; ODDS RATIO; QUESTIONNAIRES; RISK FACTORS; SINGLE-PARENT FAMILY; SOCIOECONOMIC FACTORS;

EID: 49049110094     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.097501     Document Type: Article

References (35)

1. Trotter CL, Ramsay ME, Slack MPE. Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up immunisation campaign. Commun Dis Public Health 2003;6:55-8.
2. Ramsay M, McVernon J, Andrews NJ, et al. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis 2003;188:481-5.
3. Trotter LC, McVernon J, Andrews JN, et al. Antibody to Haemophilus influenzae type b after routine and catch-up vaccination. Lancet 2003;361:1523-4.
4. McVernon J, Andrews N, Slack PM, et al. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet 2003;361:1521-3.
5. Farrand RJ. Recurrent haemophilus septicaemia and immunoglobulin deficiency. Arch Dis Child 1970;45:582-4.
6. Broome CV. Epidemiology of Haemophilus influenzae type b infections in the United States. Pediatr Infect Dis J 1987;6:779-82.
7. Goldblatt D, Johnson M, Evans J. Antibody responses to Haemophilus influenzae type b conjugate vaccine in sickle cell disease. Arch Dis Child 1996;75:159-61.
8. Vadheim CM, Greenberg DP, Bordenave N, et al. Risk factors for invasive Haemophilus influenzae type b in Los Angeles county children 18-60 months of age. Am J Epidemiol 1992;136:221-35.
9. Fogarty J, Moloney AC, Newell JB. The epidemiology of Haemophilus influenzae type b disease in the Republic of Ireland. Epidemiol Infect 1995;114:451-63.
10. Takala AK, Eskola J, Palmgren J, et al. Risk factors of invasive Haemophilus influenzae type b disease among children in Finland. J Paediatrics 1989;115:694-701.
11. Silfverdal SA, Bodin L, Hugosson S, et al. Protective effect of breastfeeding on invasive Haemophilus influenzae infection: a case-control study in Swedish preschool children. Int J Epidemiol 1997;26:443-50.
12. Ounsted C. Haemophilus influenzae meningitis. A possible ecological factor. Lancet 1950;255:161-2.
13. Ounsted C. Ecology of Haemophilus influenzae meningitis. Lancet 1951;257:800-1.
14. Turk DC. An investigation of the family background of acute haemophilus infections of children. J Hygiene 1975:315-32.
15. Istre GR, Conner JS, Broome CV, et al. Risk factors for primary invasive Haemophilus influenzae disease: increased risk from day care attendance and school-aged household members. J Paediatrics 1985;106:190-5.
16. Zielinski A, Kwon CB, Tomaszunas-Baszcyzk J, et al. Risk of Haemophilus influenzae type b meningitis in Polish children varies directly with number of siblings: possible implications for vaccination strategies. Eur J Epidemiol 2003;18:917-22.
17. Cochi SL, Fleming DW, Hightower AW, et al. Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J Paediatr 1986;108:887-96.
18. Clements DA, Guise IA, MacInnes SJ, et al. Haemophilus influenzae type b infections in Victoria, Australia, 1985-1989. J Infect Dis 1992;165:S33-44.
19. Redmond SR, Pichichero M. Hemophilus influenzae type b disease. An epidemiologic study with speial reference to day-care centers. JAMA 1984;252:2581-4.
20. Petersen GM, Silimperi DR, Chiu C-Y, et al. Effects of age, breast feeding, and household structure on Haemophilus influenzae type b disease risk and antibody acquisition in Alaskan Eskimos. Am J Epidemiol 1991;134:1212-21.
21. Wolff M, Moulton LH, Necomer W, et al. A case-control study of risk factors for Haemophilus influenzae type b disease in Navajo children. Am J Trop Med Hyg 1999;60:263-6.
22. Olowokure B, Spencer NJ, Hawker JI, et al. Changing socioeconomic risk factors for invasive H influenzae disease after the introduction of conjugate vaccine. J Infect 2003;46:46-8.
23. Olowokure B, Spencer JN, Hawker IJ, et al. Invasive Haemophilus influenzae disease: an ecological study of sociodemographic risk factors before and after the introduction of Hib conjugate vaccine. Eur J Epidemiol 2003;18:363-7.
24. Booy R, Heath PT, Slack MPE, et al. Vaccine failures after primary immunisation with haemophilus influenzae type b conjugate vaccine without booster. Lancet 1997;349:1197-202.
25. Heath PT, Booy R, Griffiths H, et al. Clinical and immunological risk factors associated with Hib conjugate vaccine failure in childhood. Clin Infect Dis 2000;31:973-80.
26. Heath PT, Booy R, McVernon J, et al. Hib vaccination in infants born prematurely. Arch Dis Child 2003;88:206-10.
27. Jafari HS, Adams WG, Robinson KA, et al. Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. Am J Public Health 1999;89:364-8.
28. Muhlemann K, Alexander ER, Weiss NS, et al. Risk factors for invasive Haemophilus influenzae disease among children 2-16 years of age in the vaccine era, Switzerland 1991-3. Int J Epidemiol 1996;25:1280- 5.
29. Fleming MD, Charlton RJ. Morbidity and healthcare utilisation of children in households with one adult: comparative observational study. BMJ 1998;316:1572-6.
30. McMunn MA, Nazroo YJ, Marmot GM, et al. Children's emotional and behavioural well-being and the family environment: findings from the Health Survey for England. Soc Sci Med 2001;53:423-40.
31. Holmes SJ, Lucas AH, Osterholm MT, et al. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. JAMA 1991;266:1960-5.
32. Holmes SJ, Granoff DM. Prevention of Haemophilus influenzae type b disease by vaccination. The Biology of Haemophilus influenzae type b vaccine failure. J Infect Dis 1992;165:S121-8.
33. Breukels MA, Spanjaard L, Sanders LAM, et al. Immunological charcterization of conjugated Haemophilus influenzae type b vaccine failure in infants. Clin Infect Dis 2001;32:1700-5.
34. Shackelford PG, Granoff DM, Polmar SH, et al. Subnormal serum concentrations of IgG2 in children with frequent infections associated with varied patterns of immunologic dysfunction. J Paediatr 1990;116:529-38.
35. McVernon J, Johnson DP, Pollard JA, et al. Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure. Arch Dis Child 2003;88:379-83.